A complete application in a minute
Tailored resume and cover letter, ready to send.
The University of Pennsylvania's Perelman School of Medicine invites applications for postdoctoral researchers to join a vibrant, interdisciplinary team probing mechanisms of neurodegeneration and cancer. Projects focus on protein quality control, aging, metabolism, autophagy, and tumor suppression with translational potential.
Applicants should hold a PhD or MD and have a strong publication record, with rigorous experimental skills in biochemistry, cell and molecular biology.
The laboratory of Professor Xiaolu Yang at thePerelman School of Medicine, University of Pennsylvania, is seeking highly motivated postdoctoral researchers to join our dynamic and interdisciplinary team. Our research investigates fundamental mechanisms underlying neurodegeneration and cancer, with current projects focused on two major areas:
Maintaining protein homeostasis is essential for cellular function, and its progressive disruption is closely associated with aging and neurodegenerative disease. Our laboratory has discovered two previously unrecognized protein quality control (PQC) systems involving tripartite motif (TRIM) proteins and poly-Asp/Glu (polyD/E) proteins. These pathways function independently of ATP and exhibit distinct patterns of evolutionary conservation—TRIM-based PQC in animals and polyD/E-based PQC across eukaryotes—distinguishing them from established PQC mechanisms. Ongoing studies aim to define the molecular mechanisms of these pathways, elucidate their roles in aging and neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis (ALS), and explore their potential for therapeutic intervention.
The tumor suppressor p53, which is encoded by the most frequently mutated gene in human cancer, is a central regulator of cellular stress responses. Our research seeks to uncoveremerging functions of p53, with particular emphasis on its regulation of cellular metabolism and autophagy. We investigate the bidirectional interplay between p53 and cellular metabolism, including how p53 responds to metabolic cues and regulates pathways essential for biosynthesis and redox homeostasis. We also seek to identify metabolic alterations that promote tumor initiation and progression. Building on these studies, we have expanded our research to explore the roles ofmetabolism and autophagy in embryonic and cancer stem cell biology.
For more information about our research, please see the following publications and laboratory website:
Lab website: https://www.med.upenn.edu/apps/faculty/index.php/g275/p20138
https://www.med.upenn.edu/yanglab/
Applicants should have recently earned, or be nearing completion of, a PhD or MD degree and demonstrate a strong publication record, rigorous experimental skills, and relevant experience in one or more research areas, such as biochemistry, cell biology, molecular biology, neuroscience, metabolism, stem cell biology, neurodegenerative disease, cancer research, or animal models.
The University of Pennsylvania (Penn), founded by Benjamin Franklin in the 18th century, is one of the oldest institutions of higher education in the United States and a distinguished member of the Ivy League. Penn is internationally recognized for excellence in education, research, and innovation. Penn’s Perelman School of Medicine, the nation’s oldest medical school, is a world-renowned center for biomedical research, education, and clinical medicine. Its highly collaborative research environment provides exceptional opportunities for interdisciplinary training and scientific development. Located in Philadelphia, a historic and culturally vibrant city, Penn’s urban campus offers convenient access to a rich array of educational, cultural, and recreational opportunities.